- Home
- ARMP vs HYPR Comparison
ARMP vs HYPR Comparison
Compare ARMP & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- HYPR
- Stock Information
- Founded
- ARMP N/A
- HYPR 2014
- Country
- ARMP United States
- HYPR United States
- Employees
- ARMP N/A
- HYPR N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- HYPR Medical Specialities
- Sector
- ARMP Health Care
- HYPR Health Care
- Exchange
- ARMP Nasdaq
- HYPR Nasdaq
- Market Cap
- ARMP 52.1M
- HYPR 55.9M
- IPO Year
- ARMP N/A
- HYPR N/A
- Fundamental
- Price
- ARMP $2.22
- HYPR $0.77
- Analyst Decision
- ARMP Strong Buy
- HYPR Strong Buy
- Analyst Count
- ARMP 1
- HYPR 3
- Target Price
- ARMP $9.00
- HYPR $1.06
- AVG Volume (30 Days)
- ARMP 18.4K
- HYPR 310.3K
- Earning Date
- ARMP 08-12-2025
- HYPR 08-07-2025
- Dividend Yield
- ARMP N/A
- HYPR N/A
- EPS Growth
- ARMP N/A
- HYPR N/A
- EPS
- ARMP N/A
- HYPR N/A
- Revenue
- ARMP $4,699,000.00
- HYPR $11,732,000.00
- Revenue This Year
- ARMP $8.43
- HYPR $12.31
- Revenue Next Year
- ARMP N/A
- HYPR $29.29
- P/E Ratio
- ARMP N/A
- HYPR N/A
- Revenue Growth
- ARMP 14.24
- HYPR 0.34
- 52 Week Low
- ARMP $0.90
- HYPR $0.53
- 52 Week High
- ARMP $3.42
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- ARMP 63.56
- HYPR 56.00
- Support Level
- ARMP $1.93
- HYPR $0.76
- Resistance Level
- ARMP $2.24
- HYPR $0.82
- Average True Range (ATR)
- ARMP 0.16
- HYPR 0.05
- MACD
- ARMP 0.03
- HYPR 0.01
- Stochastic Oscillator
- ARMP 104.55
- HYPR 72.94
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.